Neurofeedback as a nonpharmacological treatment for adults with attention-deficit/hyperactivity disorder (ADHD): Study protocol for a randomized controlled trial

Kerstin Mayer, Sarah Wyckoff, Andreas J. Fallgatter, Ann Christine Ehlis, Ute Strehl

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background: Neurofeedback has been applied effectively in various areas, especially in the treatment of children with attention-deficit/hyperactivity disorder (ADHD). This study protocol is designed to investigate the effect of slow cortical potential (SCP) feedback and a new form of neurofeedback using near-infrared spectroscopy (NIRS) on symptomatology and neurophysiological parameters in an adult ADHD population. A comparison of SCP and NIRS feedback therapy methods has not been previously conducted and may yield valuable findings about alternative treatments for adult ADHD. Methods/Design: The outcome of both neurofeedback techniques will be assessed over 30 treatment sessions and after a 6-month follow-up period, and then will be compared to a nonspecific biofeedback treatment. Furthermore, to investigate if treatment effects in this proof-of-principle study can be predicted by specific neurophysiological baseline parameters, regression models will be applied. Finally, a comparison with healthy controls will be conducted to evaluate deviant pretraining neurophysiological parameters, stability of assessment measures, and treatment outcome. Discussion: To date, an investigation and comparison of SCP and NIRS feedback training to an active control has not been conducted; therefore, we hope to gain valuable insights in effects and differences of these types of treatment for ADHD in adults. Trial registration: This study is registered with the German Registry of Clinical Trials:DRKS00006767, date of registration: 8 October 2014.

Original languageEnglish (US)
Article number174
JournalTrials
Volume16
Issue number1
DOIs
StatePublished - Apr 18 2015
Externally publishedYes

Fingerprint

Neurofeedback
Attention Deficit Disorder with Hyperactivity
Randomized Controlled Trials
Near-Infrared Spectroscopy
Therapeutics
Registries
Clinical Trials

Keywords

  • Adult ADHD
  • Biofeedback
  • Neurofeedback
  • NIRS
  • SCP
  • Therapy

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology (medical)

Cite this

Neurofeedback as a nonpharmacological treatment for adults with attention-deficit/hyperactivity disorder (ADHD) : Study protocol for a randomized controlled trial. / Mayer, Kerstin; Wyckoff, Sarah; Fallgatter, Andreas J.; Ehlis, Ann Christine; Strehl, Ute.

In: Trials, Vol. 16, No. 1, 174, 18.04.2015.

Research output: Contribution to journalArticle

@article{c5d15feab74445dc87e5f4869be664f1,
title = "Neurofeedback as a nonpharmacological treatment for adults with attention-deficit/hyperactivity disorder (ADHD): Study protocol for a randomized controlled trial",
abstract = "Background: Neurofeedback has been applied effectively in various areas, especially in the treatment of children with attention-deficit/hyperactivity disorder (ADHD). This study protocol is designed to investigate the effect of slow cortical potential (SCP) feedback and a new form of neurofeedback using near-infrared spectroscopy (NIRS) on symptomatology and neurophysiological parameters in an adult ADHD population. A comparison of SCP and NIRS feedback therapy methods has not been previously conducted and may yield valuable findings about alternative treatments for adult ADHD. Methods/Design: The outcome of both neurofeedback techniques will be assessed over 30 treatment sessions and after a 6-month follow-up period, and then will be compared to a nonspecific biofeedback treatment. Furthermore, to investigate if treatment effects in this proof-of-principle study can be predicted by specific neurophysiological baseline parameters, regression models will be applied. Finally, a comparison with healthy controls will be conducted to evaluate deviant pretraining neurophysiological parameters, stability of assessment measures, and treatment outcome. Discussion: To date, an investigation and comparison of SCP and NIRS feedback training to an active control has not been conducted; therefore, we hope to gain valuable insights in effects and differences of these types of treatment for ADHD in adults. Trial registration: This study is registered with the German Registry of Clinical Trials:DRKS00006767, date of registration: 8 October 2014.",
keywords = "Adult ADHD, Biofeedback, Neurofeedback, NIRS, SCP, Therapy",
author = "Kerstin Mayer and Sarah Wyckoff and Fallgatter, {Andreas J.} and Ehlis, {Ann Christine} and Ute Strehl",
year = "2015",
month = "4",
day = "18",
doi = "10.1186/s13063-015-0683-4",
language = "English (US)",
volume = "16",
journal = "Trials",
issn = "1745-6215",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Neurofeedback as a nonpharmacological treatment for adults with attention-deficit/hyperactivity disorder (ADHD)

T2 - Study protocol for a randomized controlled trial

AU - Mayer, Kerstin

AU - Wyckoff, Sarah

AU - Fallgatter, Andreas J.

AU - Ehlis, Ann Christine

AU - Strehl, Ute

PY - 2015/4/18

Y1 - 2015/4/18

N2 - Background: Neurofeedback has been applied effectively in various areas, especially in the treatment of children with attention-deficit/hyperactivity disorder (ADHD). This study protocol is designed to investigate the effect of slow cortical potential (SCP) feedback and a new form of neurofeedback using near-infrared spectroscopy (NIRS) on symptomatology and neurophysiological parameters in an adult ADHD population. A comparison of SCP and NIRS feedback therapy methods has not been previously conducted and may yield valuable findings about alternative treatments for adult ADHD. Methods/Design: The outcome of both neurofeedback techniques will be assessed over 30 treatment sessions and after a 6-month follow-up period, and then will be compared to a nonspecific biofeedback treatment. Furthermore, to investigate if treatment effects in this proof-of-principle study can be predicted by specific neurophysiological baseline parameters, regression models will be applied. Finally, a comparison with healthy controls will be conducted to evaluate deviant pretraining neurophysiological parameters, stability of assessment measures, and treatment outcome. Discussion: To date, an investigation and comparison of SCP and NIRS feedback training to an active control has not been conducted; therefore, we hope to gain valuable insights in effects and differences of these types of treatment for ADHD in adults. Trial registration: This study is registered with the German Registry of Clinical Trials:DRKS00006767, date of registration: 8 October 2014.

AB - Background: Neurofeedback has been applied effectively in various areas, especially in the treatment of children with attention-deficit/hyperactivity disorder (ADHD). This study protocol is designed to investigate the effect of slow cortical potential (SCP) feedback and a new form of neurofeedback using near-infrared spectroscopy (NIRS) on symptomatology and neurophysiological parameters in an adult ADHD population. A comparison of SCP and NIRS feedback therapy methods has not been previously conducted and may yield valuable findings about alternative treatments for adult ADHD. Methods/Design: The outcome of both neurofeedback techniques will be assessed over 30 treatment sessions and after a 6-month follow-up period, and then will be compared to a nonspecific biofeedback treatment. Furthermore, to investigate if treatment effects in this proof-of-principle study can be predicted by specific neurophysiological baseline parameters, regression models will be applied. Finally, a comparison with healthy controls will be conducted to evaluate deviant pretraining neurophysiological parameters, stability of assessment measures, and treatment outcome. Discussion: To date, an investigation and comparison of SCP and NIRS feedback training to an active control has not been conducted; therefore, we hope to gain valuable insights in effects and differences of these types of treatment for ADHD in adults. Trial registration: This study is registered with the German Registry of Clinical Trials:DRKS00006767, date of registration: 8 October 2014.

KW - Adult ADHD

KW - Biofeedback

KW - Neurofeedback

KW - NIRS

KW - SCP

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=84930211971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930211971&partnerID=8YFLogxK

U2 - 10.1186/s13063-015-0683-4

DO - 10.1186/s13063-015-0683-4

M3 - Article

C2 - 25928870

AN - SCOPUS:84930211971

VL - 16

JO - Trials

JF - Trials

SN - 1745-6215

IS - 1

M1 - 174

ER -